These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Anthracycline cardiotoxicity in long-term survivors of childhood cancer. Scully RE; Lipshultz SE Cardiovasc Toxicol; 2007; 7(2):122-8. PubMed ID: 17652816 [TBL] [Abstract][Full Text] [Related]
11. Anthracycline cardiotoxicity and its prevention. Mott MG Ann N Y Acad Sci; 1997 Sep; 824():221-8. PubMed ID: 9382447 [No Abstract] [Full Text] [Related]
12. Pegylated liposomal doxorubicin: pharmacologic and clinical evidence of potent antitumor activity with reduced anthracycline-induced cardiotoxicity (review). Orditura M; Quaglia F; Morgillo F; Martinelli E; Lieto E; De Rosa G; Comunale D; Diadema MR; Ciardiello F; Catalano G; De Vita F Oncol Rep; 2004 Sep; 12(3):549-56. PubMed ID: 15289836 [TBL] [Abstract][Full Text] [Related]
13. Detection of anthracycline-induced cardiotoxicity. Meinardi MT; van der Graaf WT; van Veldhuisen DJ; Gietema JA; de Vries EG; Sleijfer DT Cancer Treat Rev; 1999 Aug; 25(4):237-47. PubMed ID: 10448132 [TBL] [Abstract][Full Text] [Related]
14. Anthracycline-induced cardiotoxicity: comparison of recommendations for monitoring cardiac function during therapy in paediatric oncology trials. van Dalen EC; van den Brug M; Caron HN; Kremer LC Eur J Cancer; 2006 Dec; 42(18):3199-205. PubMed ID: 17011186 [TBL] [Abstract][Full Text] [Related]
15. Role of anthracyclines in the era of targeted therapy. Cortés-Funes H; Coronado C Cardiovasc Toxicol; 2007; 7(2):56-60. PubMed ID: 17652804 [TBL] [Abstract][Full Text] [Related]
16. Monitoring of anthracycline-induced cardiotoxicity. Jannazzo A; Hoffman J; Lutz M Ann Pharmacother; 2008 Jan; 42(1):99-104. PubMed ID: 18094345 [TBL] [Abstract][Full Text] [Related]
17. Anthracyclines: cardiotoxicity and its prevention. Hale JP; Lewis IJ Arch Dis Child; 1994 Nov; 71(5):457-62. PubMed ID: 7826122 [No Abstract] [Full Text] [Related]